<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811677</url>
  </required_header>
  <id_info>
    <org_study_id>UUH 2018-04-009</org_study_id>
    <nct_id>NCT04811677</nct_id>
  </id_info>
  <brief_title>Comparison of a SegNet-based Algorithm Estimating Epifascial Fibrosis</brief_title>
  <official_title>Comparison of a SegNet-based Algorithm Quantitatively Estimating Epifascial Fibrosis in Three-dimensional Computed Tomography Images to the Clinical Lymphedema Grading Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chungnam National University Sejong Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chungnam National University Sejong Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To approval for detecting lymphedema fibrosis before its progression, verification of&#xD;
      CT-based quantification of suprafascial microscopic fibrosis has been tried.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">March 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>accuracy</measure>
    <time_frame>within 1 week after CT scanning</time_frame>
    <description>a ratio between the correctly classified pixel and all the classified pixel in one label.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First index</measure>
    <time_frame>within 1 week after CT scanning</time_frame>
    <description>(P_(Fat in Affected)+P_(Fibrosis in Affected))/(P_(Fat in Unaffected)+P_(Fibrosis in Unaffected) ) &quot; &quot;</description>
  </secondary_outcome>
  <enrollment type="Actual">27</enrollment>
  <condition>Lymphedema</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>radiology</intervention_name>
    <description>image analysis</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients who were clinically diagnosed with limb lymphedema.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients who were clinically diagnosed with unilateral limb lymphedema and who&#xD;
             underwent multi-frequency bio-electric impedance (BEI) analysis and CT scanning.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patients who were diagnosed with deep vein thrombosis, bilateral limbs&#xD;
             involvement, vascular diseases or local infection were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Chang Ho Hwang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National University Sejong Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chungnam National University Sejong Hospital</name>
      <address>
        <city>Sejong</city>
        <zip>30099</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chungnam National University Sejong Hospital</investigator_affiliation>
    <investigator_full_name>Chang Ho Hwang, MD, PhD.</investigator_full_name>
    <investigator_title>Chief director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT04811677/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

